This is a working overview of melanocortin receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-01-06. Anything still debated is marked as such rather than presented as settled.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
Control of petroleum production has been a significant driver of international relations during much of the 20th and 21st centuries. Organizations like OPEC have played an outsized role in international politics. Some historians and commentators have called this the "Age of Oil" With the rise of renewable energy and addressing climate change some commentators expect a realignment of international power away from petrostates.
==== Member of the Order of the British Empire (MBE) ==== Civil Division Kopu Brown. For public services, lately as Secretary of the Ministry of Internal Affairs. Naomi Iro. For services to the community.
He further dismissed India's firm stance on pursuing terrorists as a “new abnormal,” stating it did not serve the interests of either country. Bilawal Zardari faced strong criticism from the Pakistan Tehreek-e-Insaf (PTI) following his remarks suggesting that Pakistan could extradite “individuals of concern” to India as a confidence-building measure. PTI Central Information Secretary Sheikh Waqas Akram condemned the statement as undermining national security and appeasing a "hostile neighbour", calling him an “immature political child” and accusing him of lacking understanding of regional geopolitics. Akram argued that such proposals compromised Pakistan’s sovereignty and contradicted the legacy of the Pakistan Peoples Party, particularly on the Kashmir issue. He further criticized Bilawal Zardari’s political credibility and called for a leadership change within the party. Talha Saeed, son of Hafiz Saeed, condemned Bilawal Zardari remarks on the possible extradition of Pakistani citizens to India, calling them contrary to state policy and national interest, and defended his father by asserting that none of his actions were against Pakistan.
The President of India appoints a Lieutenant Governor for the union territory. A Council of Ministers led by a Chief Minister is appointed by the Lieutenant Governor from the membership of the legislative assembly. Their role is to advise the Lieutenant Governor in the exercise of functions in matters under the jurisdiction of the legislative assembly. In other matters, the Lieutenant Governor is empowered to act in his own capacity. Omar Abdullah has been chief minister of Jammu and Kashmir since October 2024. There are 42 administrative departments under the Government of Jammu and Kashmir, through which executive functions are carried out.
Sources: en.wikipedia.org
=== Evolutionary variation of homologous RNA sequences reveals folding patterns === Additional tRNA molecules were purified and sequenced. The first comparative sequence analysis was done and revealed that the sequences varied through evolution in such a way that all of the tRNAs could fold into very similar secondary structures (two-dimensional structures) and had identical sequences at numerous positions (e.g. CCA at the 3′ end). The radial four-arm structure of tRNA molecules is termed the "cloverleaf structure", and results from the evolution of sequences with common ancestry and common biological function. Since the discovery of the tRNA cloverleaf, comparative analysis of numerous other homologous RNA molecules has led to the identification of common sequences and folding patterns.
The Appalachian Mountains are a vast mountain range situated in eastern North America, extending roughly 2,050 miles (3,300 km) from central Alabama to Newfoundland along a generally southwest–northeast axis. Alongside the Appalachian Plateau province—with which they are not entirely synonymous—the mountains form a wider system comprising the region's backbone. The range's highest peak is 6,684-foot (2,037 m) Mount Mitchell in the Black Mountains subrange of North Carolina, which themselves are part of the larger Blue Ridge Mountains. Saint Pierre and Miquelon, an overseas collectivity of France, is part of the range, meaning it technically spans portions of three countries. It is geologically related to the Scottish Highlands, Atlas Mountains, Scandinavian Mountains, and Ouachitas, as these ranges all originally belonged to the sprawling Central Pangean Mountains before plate tectonics tore them apart. The geologic processes that led to the formation of the Appalachian Mountains started around 1.1 billion years ago with the creation of supercontinent Rodinia, and many Precambrian rocks and minerals created via this process remain visible today in the range's outcrops. The modern Appalachians and their relatives themselves were created by a series of three distinct orogenies beginning approximately 480 million years ago, making them one of the oldest surviving mountain ranges in the world.
== Obesity == The British medical journal, Lancet, published a study examining trends in mean body mass index (BMI) for adults in all countries. Obesity was defined as a BMI score greater than 30. Age standardized obesity rates in 2014, broken down by country and gender were extracted from these data. Included were all countries with a population of 10 million or more. Thailand ranked 34 of the top 55 countries (of 200 countries total irrespective of population) (1=most obese). Other ASEAN nations ranked were Malaysia, 32; Indonesia, 41; Philippines, 42; Myanmar, 48; Vietnam, 55. In all ASEAN nations listed, the rate of female obesity exceeded that of males.
I. Partial-thickness defects A partial-thickness defect is a wound with adequate soft-tissue coverage of the underlying nasal skeleton, yet is too large for primary intention closure, with sutures. Based upon the locale of the wound, the surgeon has two options for correcting such a wound: (i) healing the wound by secondary intention (re-epithelialisation); and (ii) healing the wound with a full-thickness skin graft. Moreover, because it avoids the patched appearance of a skin-graft surgical correction, healing by secondary intention can successfully repair nasal wounds up to 10 mm in diameter; and, if the resultant scar proves aesthetically unacceptable, it can be revised later, after the wound has healed. In the event, larger nasal wounds (defects) do successfully heal by secondary intention, but do present two disadvantages. First, the resultant scar often is a wide patch of tissue that is aesthetically inferior to the scars produced with other nasal-defect correction techniques; however, the skin of the medial canthus is an exception to such scarring. The second disadvantage to healing by secondary intention is that the contracture of the wound might distort the normal nasal anatomy, which can lead to a pronounced deformity of the alar rim area. For this reason, healing by secondary intention generally is not recommended for defects of the distal third of the nose; nonetheless, the exception is a small wound directly upon the nasal tip.
The two substrates of this enzyme are propylene glycol and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are L-lactaldehyde, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is propane-1,2-diol:NADP+ oxidoreductase. Other names in common use include lactaldehyde (reduced nicotinamide adenine dinucleotide phosphate), reductase, NADP+-1,2-propanediol dehydrogenase, propanediol dehydrogenase, 1,2-propanediol:NADP+ oxidoreductase, and lactaldehyde reductase (NADPH).
Sources: en.wikipedia.org
== Natural occurrence == Naturally occurring fusion genes are most commonly created when a chromosomal translocation replaces the terminal exons of one gene with intact exons from a second gene. This creates a single gene that can be transcribed, spliced, and translated to produce a functional fusion protein. Many important cancer-promoting oncogenes are fusion genes produced in this way. Examples include:
Antifreeze proteins are a perfect example of convergent evolution. Different small proteins with a flat surface which is rich in threonine from different organisms are selected to bind to the surface of ice crystals. "These include two proteins from fish, the ocean pout and the winter flounder, and three very active proteins from insects, the yellow mealworm beetle, the spruce budworm moth, and the snow flea." RNA-binding proteins which contain RNA-binding domain (RBD) and the cold-shock domain (CSD) protein family are also an example of convergent evolution. Except that they both have conserved RNP motifs, other protein sequence are totally different. However, they have a similar function. Blue-light-receptive cryptochrome expressed in the sponge eyes likely evolved convergently in the absence of opsins and nervous systems. The fully sequenced genome of Amphimedon queenslandica, a demosponge larvae, lacks one vital visual component: opsin-a gene for a light-sensitive opsin pigment which is essential for vision in other animals. The structure of immunoglobulin G-binding bacterial proteins A and H do not contain any sequences homologous to the constant repeats of IgG antibodies, but they have similar functions. Both protein G, A, H are inhibited in the interactions with IgG antibodies (IgGFc) by a synthetic peptide corresponding to an 11-amino-acid-long sequence in the COOH-terminal region of the repeats.
=== Cot–Cz === Frank Albert Cotton (1930–2007), American chemist known for research on transition metals and as coauthor of Advanced Inorganic Chemistry, 2000 Wolf Prize in Chemistry Charles Coulson (1910–1974), British theoretical chemist, pioneer of the application of quantum theory to problems of molecular structure Archibald Scott Couper (1831–1892), British chemist who developed the concept of tetravalent carbon atoms linking together to form large molecules James Crafts (1839–1917), American chemist, developer of Friedel–Crafts reaction for alkylation and acylation Donald J. Cram (1919–2001), American chemist, winner of the 1987 Nobel Prize in Chemistry for development of molecules with structure-specific interactions of high selectivity William Crookes (1832–1919), British chemist who discovered thallium, and was a pioneer of vacuum tubes Alexander Crum Brown (1838–1922), Scottish organic chemist who developed the concept of tetravalent carbon atoms linking together to form large molecules Paul J.
In 2018, Schleip spearheaded the Fascial Net Plastination Project (FNPP), ananatomical research initiative designed to plastinate and study the human fascial network. The FNPP brought together experts in anatomy, dissection, and plastination, to plastinate a complete human fascia specimen. The project created a full-body human fascia plastinate named FR:EIA (Fascia Revealed: Educating Interconnected Anatomy). FR:EIA was unveiled at the 2021 Fascia Research Congress and is currently on display at the Body Worlds exhibition in Berlin.
== History == Founded in 1993 by Jack Owoc, Bang's parent company manufactured and distributed sports supplements and performance beverages under the brand name VPX. Other products distributed by Vital included Redline, Noo Fuzion, and Meltdown. In 2012, Vital created Bang, marketed as a low sugar carbonated energy drink and with the mission to make high-quality nutritional supplements backed by scientific research. In 2017, it was announced that Bang would offer a caffeine-free variant of the beverage, using beta-alanine in place of caffeine. In 2019, the company opened a manufacturing and distribution facility in Phoenix, Arizona, which operates alongside their facility in Pembroke Pines, Florida. In April 2020, PepsiCo entered into an exclusive distribution agreement with VPX to distribute Bang in the United States. On November 17, 2020, it gave PepsiCo a notice of termination; an emergency arbitrator ruled in December 2020 that Pepsi remained the exclusive distributor of Bang drinks until 2023. VPX resolved their disputes with PepsiCo and transitioned away from their distribution in June 2022. In August 2022, it was reported that Keurig Dr Pepper was in talks to purchase VPX; these talks fell apart shortly after the reports surfaced. On October 10, 2022, Bang's parent company filed for Chapter 11 bankruptcy protection. Three months after Owoc was removed and John DiDonato was named interim CEO of VPX, Monster Beverage reached an agreement for its purchase on June 28, 2023, this was completed one month later.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.